Revelation Biosciences Inc. (REVBW) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Revelation Biosciences In...

    NASDAQ: REVBW · Real-Time Price · USD
    0.01
    -0.00 (-10.71%)
    At close: Jun 09, 2025, 2:31 PM

    Revelation Biosciences Cash Flow Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -15.04M -120.25K -10.83M -11.99M
    Depreciation & Amortization
    		 27.92K 25.05K 25.05K 16.78K
    Stock-Based Compensation
    		 168.85K 155.72K 301.12K 470.88K
    Other Working Capital
    		 -2.85M 232.47K -64.93K 625.86K
    Other Non-Cash Items
    		 -56.44K -8.33M 14.96K 52.38K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -3.42M 982.13K -730.97K 356.22K
    Operating Cash Flow
    		 -18.32M -7.29M -11.22M -11.09M
    Capital Expenditures
    		 -19.17K -4 n/a -131.96K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a 525.29K
    Other Investing Acitivies
    		 n/a n/a n/a -525.29K
    Investing Cash Flow
    		 -19.17K n/a n/a -131.96K
    Debt Repayment
    		 n/a n/a -796.88K n/a
    Common Stock Repurchased
    		 n/a -5K -7.65M n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a 34.00 11.54M n/a
    Financial Cash Flow
    		 12.85M 14.03M 15.2M 8M
    Net Cash Flow
    		 -5.49M 6.74M 3.98M -3.22M
    Free Cash Flow
    		 -18.34M -7.29M -11.22M -11.22M

    Add to Watchlist